![](/img/cover-not-exists.png)
A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520
Puvvada, Soham D., Li, Hongli, Rimsza, Lisa M., Bernstein, Steven H., Fisher, Richard I., LeBlanc, Michael, Schmelz, Monika, Glinsmann-Gibson, Betty, Miller, Thomas P., Maddox, Anne-Marie, Friedberg,Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2015.1135431
Date:
January, 2016
File:
PDF, 2.08 MB
english, 2016